Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. as Placement Agent for $2.1 Million Private Placement
Press Release – New York, NY – April 17, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that between November 2016 and March 2017 it represented Laidlaw & Company (UK) Ltd. as the exclusive placement agent in a private placement of equity securities of Protea Biosciences Group, Inc. (OTCQB: PRGB), a molecular information company that has developed a technology which enables the direct analysis, mapping and display of biologically active molecules in living cells and tissue samples.
In connection with the offering, Protea Biosciences Group, Inc. accepted subscriptions for an aggregate of $2,095,430 in gross proceeds from the sale of 209.54 units comprised of an aggregate of (a) 27,939,060 shares of Common Stock, (b) 27,939,060 Class A Warrants and (c) 27,939,060 Class B Warrants.
The Sichenzia Ross Ference Kesner LLP team was led by partners Harvey Kesner and Avital Perlman and associate Evan Berger.
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- Medical Marijuana Dispensary Business Project 1493, LLC Announces Share Exchange Agreement with Public Entity & Simultaneous $3.3 Million PIPE Financing - June 16, 2017
- Sichenzia Ross Ference Kesner LLP Represents Immuron Limited on $6.1M IPO and NASDAQ listing - June 15, 2017
- Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar, and Fordham Financial Management in $6.6 Registered Direct offering of Ampio Pharmaceuticals, Inc. - June 8, 2017